This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Dr. Stuart Sievers, PhD
Senior Director, Discovery Research at Capstan Therapeutics
Speaker

Profile

Dr. Stuart Sievers is the Senior Director of Discovery Research at Capstan Therapeutics. His team focuses on antibody and chimeric antigen receptor (CAR) discovery and engineering, supporting the development of targeted lipid nanoparticles to engineer cells in vivo. Previously, Stuart worked at Kite Pharma, directing antibody discovery and CAR screening efforts to support the development of clinical- and commercial-stage cell therapies. Stuart earned his undergraduate degree in Biochemistry from UC Berkeley, his PhD in Biochemistry from UCLA under David Eisenberg, and completed postdoctoral research at Caltech with Pamela Bjorkman. His research has led to publications and patents on a variety of topics, including amyloid fibril formation and inhibition, antibody and CAR design, and novel reagents for CAR detection.

Agenda Sessions

  • Accelerating Antibody Drug Discovery with GenScript's MonoRab™ & TurboCHO™ Platforms AND The Development of a Novel CD8-targeting Lipid Nanoparticle to Transiently Engineer CD8+ T Cells in vivo Using mRNA to Express a CD19 CAR

    12:15pm